Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma.
Pitiyarachchi O, Lee YC, Sim HW, Srirangan S, Mapagu C, Kirk J, Harnett PR, Balleine RL, Bowtell DDL, Samimi G, Brand AH, Marsh DJ, Beale P, Anderson L, Bouantoun N, Provan P; INOVATe Investigators; Ramus SJ, DeFazio A, Friedlander M. Pitiyarachchi O, et al. Among authors: srirangan s. Transl Oncol. 2023 May;31:101638. doi: 10.1016/j.tranon.2023.101638. Epub 2023 Feb 18. Transl Oncol. 2023. PMID: 36805919 Free PMC article.
Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.
Werner B, Yuwono N, Duggan J, Liu D, David C, Srirangan S, Provan P; INOVATe Investigators; DeFazio A, Arora V, Farrell R, Lee YC, Warton K, Ford C. Werner B, et al. Among authors: srirangan s. Gynecol Oncol. 2021 Sep;162(3):720-727. doi: 10.1016/j.ygyno.2021.06.028. Epub 2021 Jul 5. Gynecol Oncol. 2021. PMID: 34454680
BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition.
Moujaber T, Etemadmoghadam D, Kennedy CJ, Chiew YE, Balleine RL, Saunders C, Wain GV, Gao B, Hogg R, Srirangan S, Kan C, Fereday S, Traficante N; Australian Ovarian Cancer Study; Patch AM, Pearson JV, Waddell N, Grimmond SM, Dobrovic A, Bowtell DDL, Harnett PR, deFazio A. Moujaber T, et al. Among authors: srirangan s. JCO Precis Oncol. 2018 Nov;2:1-14. doi: 10.1200/PO.17.00221. JCO Precis Oncol. 2018. PMID: 35135122
Widespread lytic lesions-A metastatic or vasculitic process?
Khan F, Srirangan S, El-Miedany Y, Madaan S. Khan F, et al. Among authors: srirangan s. Int J Surg Case Rep. 2016;18:18-20. doi: 10.1016/j.ijscr.2015.11.023. Epub 2015 Nov 27. Int J Surg Case Rep. 2016. PMID: 26684863 Free PMC article.
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.
Gale RE, Hills R, Kottaridis PD, Srirangan S, Wheatley K, Burnett AK, Linch DC. Gale RE, et al. Among authors: srirangan s. Blood. 2005 Nov 15;106(10):3658-65. doi: 10.1182/blood-2005-03-1323. Epub 2005 Aug 2. Blood. 2005. PMID: 16076872 Free article.